✓
Open
18 Jun 2026
✓
Close
22 Jun 2026
3
Allotment
—
✓
Listing
Thu, Jun 25, 2026
Price Band
₹196 to ₹208
Issue Size
14,53,800 shares (agg. up to ₹30 Cr)
Lot Size
600 Shares
Listing Date
Thu, Jun 25, 2026
Latest GMP
₹145
Est. Gain
69.71%
✦ AI Insight
GMP Trend
25-06-2026₹145Est. ₹353+69.71%
24-06-2026₹145Est. ₹353+69.71%
23-06-2026₹95Est. ₹303+45.67%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 267.95x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Jan 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 66.07 | 56.52 | 34.65 |
| Total Income | 41.94 | 45.97 | 24.37 |
| Profit After Tax | 5.74 | 7.23 | 2.14 |
| EBITDA | 10.34 | 11.41 | 4.08 |
| NET Worth | 28.52 | 22.78 | 6.21 |
| Reserves and Surplus | 24.49 | 18.75 | 2.93 |
| Total Borrowing | 26.73 | 22.16 | 15.13 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | Mainboard | ₹3,395.00 Cr | ₹570 | 70.62 | ₹730.35 | +28.13% | ₹957.80 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | 14.05 |
| 2 | Funding the working capital requirements of the Company | 8.25 |
| 3 | General Corporate Purposes | 3.97 |
| 4 | Public Issue Expenses | 3.97 |
| Total | 30.24 |
About Avience Biomedicals IPO
Updated on Aug 5, 2026
Contact Details
Avience Biomedicals Ltd. AddressC-11, Block-CCommunity CentreJanakpuri A-3Delhi, New Delhi, 1100581800-12-04-636info@avienbio.comVisit Website